KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Common Equity (2016 - 2026)

Merck has reported Common Equity over the past 18 years, most recently at $45.9 billion for Q1 2026.

  • Quarterly Common Equity fell 5.1% to $45.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $45.9 billion through Mar 2026, down 5.1% year-over-year, with the annual reading at $52.6 billion for FY2025, 13.44% up from the prior year.
  • Common Equity was $45.9 billion for Q1 2026 at Merck, down from $52.6 billion in the prior quarter.
  • Over five years, Common Equity peaked at $52.6 billion in Q4 2025 and troughed at $37.6 billion in Q4 2023.
  • The 5-year median for Common Equity is $44.6 billion (2024), against an average of $44.8 billion.
  • Year-over-year, Common Equity surged 51.46% in 2022 and then decreased 18.29% in 2023.
  • A 5-year view of Common Equity shows it stood at $46.1 billion in 2022, then fell by 18.29% to $37.6 billion in 2023, then grew by 23.22% to $46.4 billion in 2024, then increased by 13.44% to $52.6 billion in 2025, then dropped by 12.69% to $45.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Common Equity are $45.9 billion (Q1 2026), $52.6 billion (Q4 2025), and $51.9 billion (Q3 2025).